WCN26-5997 Clinical impact of immunosuppressive combination therapy in MPO-ANCA–associated rapidly progressive glomerulonephritis: a retrospective comparison with steroid monotherapy

Read full text Summarise with VIRAT
Authors: Kentaro Watanabe, Akiyuki Zushi, Toru Mitsuhashi, Kyohei Higashi, Rina Sanoh, Tomoko Konishi, Jiaqi Xu, Takahiro Kida, Misaki Nakamura, Motoyasu Kurahashi, Mana Nishikawa, Motoko Kanzaki
+3 more Kosuke Fukuoka, Kenichiro Asano, NORIAKI SHIMADA
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) predominantly affects elderly individuals and often presents with rapidly progressive glomerulonephritis (RPGN). The standard treatment consists of corticosteroids combined with immunosuppressive agents. However, in elderly patients, adverse events such as severe infections are major concerns, and tailoring treatment intensity is essential.

Fields of Study & Subjects

Vasculitis and related conditions Renal Diseases and Glomerulopathies Systemic Lupus Erythematosus Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
106254–106254
Publication date
25 March 2026
Language
EN